Sanofi angiogenesis deal with CEPH

Cephalon (CEPH) and Sanofi- Synthelabo (Paris, France) partnered to develop oral small molecule angiogenesis inhibitors based on CEPH's kinase inhibitor technology. The companies will share developmen...